Skip To Main Content

Effectiveness of an on-campus pharmacist directed Tdap immunization program

BreAnna R. Meinzer, PharmD, CTTS, Michael J. Rush, PharmD, BCACP, CDE, CTTS, Karen L. Kier, PhD, MSc, RPh, BCPS, BCACP, CTTS, Amy M. Fanous, PharmD, BCACP, CTTS, Colin S. Frank, PharmD, CTTS
Ohio Northern University
Institution if not ONU: 


Despite a slight increase in Tdap immunization rates, they still fall extremely low among adolescents and adults across the nation. Because pharmacists are among the most trusted health care professionals and are also easily accessible, they serve as the perfect bridge to increase immunization rates despite a shortage in primary care physicians. The study’s purpose is to determine the effectiveness of a pharmacist led immunization program on a university campus in an ambulatory care clinic for employees and students. This is meant to show the effectiveness of pharmacists and how they increase population health in the ambulatory care setting.


This study is pending IRB approval. Employees, retirees, and students (18 years and older) will be screened to see if they meet the criteria for a Tdap vaccination. Patients who have a high risk of contracting pertussis will schedule an appointment with a pharmacist. At the appointment, past medical history, current medications, demographics, and vaccine safety data will be collected. The vaccine will be administered and while the patient is observed, they will complete an assessment about the patient’s perception of a pharmacist’s impact on vaccination rates.  Anyone included in the study will also be welcomed to attend a “Lunch and Learn” program that will discuss the difference between the Tdap vaccine and the decennial tetanus booster, the indications for the Tdap vaccine, and the safety of vaccinations. Data will be de-identified, locked in a restricted room and in a password-protected document, and protected through HIPAA standards.  Screening tools, surveys, and assessments will become part of the patient’s medical chart also stored in the locked, restricted room. Outcome variables will be analyzed by descriptive and inferential statistics. Data will be presented in aggregate form.



American Society of Health-System Pharmacists Midyear Clinical Meeting
PDF icon b_meinzer_tdap.pdf747.21 KB